NORLUX Neuro-Oncology Laboratory

Medicine & Life Sciences

1. Glioblastoma 100%
2. Glioma 53%
3. Neoplasms 45%
4. Brain Neoplasms 31%
5. Heterografts 24%
6. Genes 18%
7. Actins 18%
8. Actin Cytoskeleton 17%
9. Microglia 17%
10. Proteins 15%
11. Growth 13%
12. Therapeutics 13%
13. Mutation 13%
14. Brain 12%
15. Proteomics 12%
16. Stem Cells 12%
17. Phenotype 12%
18. Organoids 11%
19. Isocitrate Dehydrogenase 11%
20. Arabidopsis 10%
21. Cell Line 10%
22. Neoplastic Stem Cells 9%
23. Long Noncoding RNA 8%
24. ErbB Receptors 8%
25. In Vitro Techniques 8%
26. Macrophages 8%
27. Autophagy 7%
28. Temozolomide 7%
29. itaconic acid 7%
30. Hypoxia 7%
31. Pharmaceutical Preparations 7%
32. alpha-Synuclein 7%
33. Alginates 7%
34. Bevacizumab 7%
35. Gene Expression 6%
36. Zebrafish 6%
37. RNA Interference 6%
38. LIM Domain Proteins 6%
39. Astrocytes 6%
40. Vascular Endothelial Growth Factor A 6%
41. Molecular Evolution 6%
42. Tumor Microenvironment 6%
43. Tobacco 6%
44. Arabidopsis Proteins 6%
45. Animal Models 6%
46. Neurodegenerative Diseases 6%
47. Blood-Brain Barrier 6%
48. Survival 6%
49. Parkinson Disease 5%
50. Breast Neoplasms 5%
51. Immunotherapy 5%
52. Precision Medicine 5%
53. Oligodendroglioma 5%
54. Technology 5%
55. Big Data 5%
56. Sumoylation 5%
57. Down-Regulation 5%
58. Myeloid-Derived Suppressor Cells 5%
59. Multimodal Imaging 5%
60. Citric Acid Cycle 5%
61. Axitinib 5%
62. Cell Encapsulation 5%
63. Inflammation 5%
64. Shigella 5%
65. Natural Killer Cells 5%
66. Genome 5%